Anavex Life Sciences Corp (AVXL)

[B60611]

Anavex's delay issues have always been more in the enrolling (AVATAR was half enrolled in May 2020 and took another 15 months to enroll 18 or so patients) than the data analysis (albeit that's been on the slow side, too), so I agree with Excellence likely reading out in 2023. But, the ALZ trial ends in mid-May, so IMO, it should read out by the end of summer, which would be 4 full months. I'm a skeptic, but even I'd be shocked if it went past Thanksgiving, as that would be > 6 months. I wonder when the run-up into ALZ data will commence? If CRTX is instructive, they sky rocketed 2.5 months before data was expected (perhaps Mid-July for us), but rose steadily (doubled, in fact) in the 3 months before that. So, maybe we'll begin our ascent in April, and we have the possibility of so much other news between now and the ALZ readout which CRTX did not have.

BTW, the June 8, 2021 completed ALZ enrollment PR said TLD "by mid-2022," which is of course stupidly unrealistic. Missling needs to get his shit together.